Title:
リン酸塩過剰血症のための鉄(II)含有治療剤
Document Type and Number:
Japanese Patent JP2009542653
Kind Code:
A
Abstract:
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Alternatively, a pharmaceutica composition comprises a pharmaceutically acceptable ferrous iron compound and pharmaceutically acceptable carrier, wherein the ferrous iron compound is selected from the group consisting of iron(II) acetate, iron(II) citrate, iron(II) ascorbate, iron(II) oxalate, iron(II) oxide, iron(II) carbonate, iron(II) carbonate saccharated, iron(II) formate, iron(II) sulfate, iron(II) chloride, iron(II) acetylacetonate and combinations thereof. A method of treating a subject with hyperphosphatemia comprises administering to the subject an effective amount of a pharmaceutical composition as described above.
Inventors:
Hoover, Chad, Sea.
Dar, Pradeep, Kay.
Holmes-Farley, Stephen, Randall
Dar, Pradeep, Kay.
Holmes-Farley, Stephen, Randall
Application Number:
JP2009518197A
Publication Date:
December 03, 2009
Filing Date:
June 25, 2007
Export Citation:
Assignee:
Genzyme Corporation
International Classes:
A61K31/295; A61K31/785; A61K31/787; A61K33/00; A61K33/06; A61K33/26; A61K33/30; A61K45/00; A61P3/00; A61P7/00
Attorney, Agent or Firm:
Yoshinori Hosoda